Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

Scott A. Halperin; Rituparna Das; Matthew T. Onorato; Kenneth Liu; Jason Martin; Rebecca J. Grant-Klein; Rick Nichols; Beth Ann Coller; Frans A. Helmond; Jakub K. Simon

doi:10.1093/infdis/jiz241

Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

Scott A. Halperin, Rituparna Das, Matthew T. Onorato, Kenneth Liu, Jason Martin, Rebecca J. Grant-Klein, Rick Nichols, Beth Ann Coller, Frans A. Helmond, Jakub K. Simon

Economics, Econometrics and Finance

科研成果: 期刊稿件 › 文章 › 同行评审

44 引用（Scopus）

源语言	英语
页（从-至）	1127-1135
页数	9
期刊	Journal of Infectious Diseases
卷	220
期	7
DOI	https://doi.org/10.1093/infdis/jiz241
出版状态	已出版 - 8月 30 2019

!!!ASJC Scopus Subject Areas

传染病学
免疫学和过敏症

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1093/infdis/jiz241

其它文件与链接

引用此

Halperin, S. A., Das, R., Onorato, M. T., Liu, K., Martin, J., Grant-Klein, R. J., Nichols, R., Coller, B. A., Helmond, F. A., & Simon, J. K. (2019). Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults. Journal of Infectious Diseases, 220(7), 1127-1135. https://doi.org/10.1093/infdis/jiz241

Halperin, SA, Das, R, Onorato, MT, Liu, K, Martin, J, Grant-Klein, RJ, Nichols, R, Coller, BA, Helmond, FA & Simon, JK 2019, 'Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults', Journal of Infectious Diseases, 卷 220, 号码 7, 页码 1127-1135. https://doi.org/10.1093/infdis/jiz241

@article{664650a5bc554797b6db139ed276e826,

title = "Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults",

keywords = "Ebola, clinical trial, immunogenicity, rVSVΔG-ZEBOV-GP, vaccine",

author = "Halperin, {Scott A.} and Rituparna Das and Onorato, {Matthew T.} and Kenneth Liu and Jason Martin and Grant-Klein, {Rebecca J.} and Rick Nichols and Coller, {Beth Ann} and Helmond, {Frans A.} and Simon, {Jakub K.}",

year = "2019",

month = aug,

day = "30",

doi = "10.1093/infdis/jiz241",

language = "English",

volume = "220",

pages = "1127--1135",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine

T2 - A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

AU - Halperin, Scott A.

AU - Das, Rituparna

AU - Onorato, Matthew T.

AU - Liu, Kenneth

AU - Martin, Jason

AU - Grant-Klein, Rebecca J.

AU - Nichols, Rick

AU - Coller, Beth Ann

AU - Helmond, Frans A.

AU - Simon, Jakub K.

PY - 2019/8/30

Y1 - 2019/8/30

KW - Ebola

KW - clinical trial

KW - immunogenicity

KW - rVSVΔG-ZEBOV-GP

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85072011798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072011798&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiz241

DO - 10.1093/infdis/jiz241

M3 - Article

C2 - 31505665

AN - SCOPUS:85072011798

SN - 0022-1899

VL - 220

SP - 1127

EP - 1135

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 7

ER -

Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此